Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00161304Phase 3Completed
Phase 3, randomised trial in androgen deficiency comparing Testosterone Enanthate with Placebo (2 arms). Primary endpoint: Changes in tissue hormones and other biomarkers in prostate tissue specimens. Started Apr 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00161304.